VERSANTIS Trademark
VERSANTIS is a USPTO trademark filed by GENFIT. Status: Registered.
Trademark Facts
| Mark | VERSANTIS |
|---|---|
| Serial Number | 79397393 |
| Registration Number | 7741625 |
| Status | Registered |
| Filing Date | 2024-04-19 |
| Registration Date | 2025-04-01 |
| Mark Type | Combined |
| Nice Classes | 009 (Electronics & Software), 042 (Software & IT), 044 (Medical Services) |
| Owner | GENFIT |
| Attorney of Record | Ronald M. Kachmarik |
| Prosecution Events | 32 |
| Latest Event | OPNX on 2025-11-30 |
Goods & Services
Downloadable and recorded software for use in the management of cancer, metabolic diseases and liver diseases, namely, software for creating customized care plans for patients, for managing patient data, for providing clinical decision support information and analytics, for managing patient medications, and for providing reporting and analytics relating to patient care; downloadable and recorded software for use in research and development of new pharmaceutical products for others, namely, software for managing, analyzing and reporting on clinical trial data; downloadable software applications for use in diagnosing medical conditions; scientific apparatus and instruments particularly for recording, processing, reproducing, and transmitting data; data processing equipment; downloadable electronic publications in the nature of brochures, newsletters, reports, medical journals and medical periodicals, in the field of prevention, diagnosis and treatment of cancer, metabolic diseases and liver diseases; downloadable electronic databases in the field of prevention, diagnosis and treatment of cancer, metabolic diseases and liver diseases; all these goods exclusively in the field of liver and metabolic diseases.; Medical services; veterinary services; medical assistance; hospital services; consultation with respect to pharmacy, namely, pharmaceutical consultation; all these services exclusively in the field of liver and metabolic diseases.; Pharmaceutical research being research for the discovery of new medicines; scientific research, particularly in the medical, biomedical, and chemical field; consultation in the field of scientific research and development of therapies; research and development of new pharmaceutical products for others; scientific research in the field of pharmacy; all these services exclusively in the field of liver and metabolic diseases.